Posted by Michael Wonder on 06 Oct 2025
Amgen makes Repatha available though AmgenNow, a direct to patient program in the US
6 October 2025 - Eligible patients can access Repatha at nearly 60% discount from the list price.
Amgen today announced the launch of AmgenNow, a new direct to patient program starting with Repatha (evolocumab).
